Literature DB >> 35184919

Perioperative Management of Immunosuppressive Medications for Rheumatoid Arthritis.

Andrew M Hresko1, Christopher J Got1, Joseph A Gil2.   

Abstract

Operations in patients with rheumatoid arthritis are complicated by the fact that most drugs used in medical management have immunosuppressive mechanisms of action, including corticosteroids and conventional synthetic and biologic disease-modifying antirheumatic drugs. In deciding to continue or discontinue these medications perioperatively, surgeons must weigh the relative risk of infection from immunosuppression against the risk of rheumatoid arthritis symptom flares from reduced medical disease control. The objective of this article is to review the existing evidence regarding perioperative management of immunosuppressive rheumatoid arthritis medications, with a specific focus on relevance to hand and upper-extremity procedures.
Copyright © 2022 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biologic synthetic disease-modifying antirheumatic drugs; conventional synthetic disease-modifying antirheumatic drugs; corticosteroids; disease-modifying antirheumatic drugs; rheumatoid arthritis

Mesh:

Substances:

Year:  2022        PMID: 35184919     DOI: 10.1016/j.jhsa.2021.09.038

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.342


  2 in total

Review 1.  Perioperative and anesthetic management of patients with rheumatoid arthritis.

Authors:  Hae-Rim Kim; Seong-Hyop Kim
Journal:  Korean J Intern Med       Date:  2022-06-03       Impact factor: 3.165

2.  Identification of genomic determinants contributing to cytokine release in immunotherapies and human diseases.

Authors:  Lipei Shao; Alejandra Pelayo; Rongye Shi; Jinxia Ma; Hui Liu; Yihua Cai; Michaela Prochazkova; Robert P Somerville; Sandhya R Panch; Nirali N Shah; David F Stroncek; Ping Jin
Journal:  J Transl Med       Date:  2022-07-28       Impact factor: 8.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.